Loading clinical trials...
Loading clinical trials...
Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer: a Phase II Trial
Conditions
Interventions
hypofractionated radiotherapy with immunotherapy
Locations
1
China
Anhui Provicial Hospital
Hefei, Anhui, China
Start Date
July 1, 2024
Primary Completion Date
July 31, 2026
Completion Date
July 31, 2027
Last Updated
September 19, 2024
NCT07336732
NCT06712355
NCT05419076
NCT06242470
NCT07161388
NCT07189455
Lead Sponsor
Anhui Provincial Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions